Bulgaria's caretaker government said that it allocated an additional 38.9 million levs ($23.0 million/19.9 million euro) to the budget of the health ministry to finance a new contract for the purchase of Veklury (INN Remdesivir), a medicine used for the treatment of Covid-19, and pay for already completed deliveries of the same medicine.
The new contract envisages the supply of at least 30,000 doses of the Veklury medicine within a period of six months, the caretaker government said in a statement on Wednesday.
Remdesivir is manufactured by US-based company Gilead Sciences and sells under the Veklury brand name. Veklury was the first medicine approved by the European Commission for treatment of COVID-19.
According to data published by the health ministry on Thursday, there are 500,112 confirmed cases of COVID-19 in Bulgaria, of which 43,520 are still active.